Project Grant R21AG085881
Award Date
9/30/24
Completion Date
8/31/26
Dollars Obligated
$850K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $825,135 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the Massachusetts General Hospital to investigate the relationships between gut microbiome-related metabolites, cerebrovascular disease, Alzheimer's disease biomarkers, and cognitive impairment. The research will leverage data from the REGARDS and CARDIA longitudinal cohort studies to examine associations between gut microbiome metabolites, brain imaging markers, and the...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Massachusetts Medical School is focused on understanding how the gut microbiome influences neurodegeneration and protects against Alzheimer's disease. The $647,979 award, effective September 30, 2024 through August 31, 2025, will leverage the C. elegans model system to: Determine how bacterial production of vitamin B12 protects against neurodegeneration pathways. Examine...
The University of South Florida received a $3,385,215 Project Grant award from the National Institute on Aging, part of the National Institutes of Health within the Department of Health and Human Services. The grant was awarded under the Aging Research program (CFDA 93.866) to fund research titled "Microbial Therapy Improves Gut Permeability to Reduce Cognitive Decline and Alzheimer's Disease." The grant will support research from August 2021 through July 2024 to study the impact of...
The National Institute on Aging (NIA) awarded a $856,580 Project Grant (CFDA 93.866 - Aging Research) to the University of Massachusetts Lowell to elucidate the microbial origins of Alzheimer's disease and related dementias (AD/ADRD) in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort. The project will generate longitudinal gut microbiome and serum metabolomic profiles for approximately 2,800 HCHS/SOL participants to investigate the role of the gut microbiome in AD/ADRD...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) provides $630,905 to the University of Wisconsin-Madison to explore the role of the gut microbiome-derived metabolite imidazole propionate (IMP) in the progression of Alzheimer's disease (AD) and related dementias (ADRD). The central hypothesis is that IMP modulates AD and ADRD pathology by altering vascular endothelial function and blood-brain barrier permeability. The research will...
The National Institute on Aging (NIA) awarded a $502,045 Project Grant (CFDA 93.866 - Aging Research) to the University of Wisconsin-Madison to test the safety and feasibility of a custom probiotic intervention among people with Alzheimer's disease (AD) dementia and preclinical AD. The study aims to evaluate secondary outcomes, such as cognitive function and plasma biomarkers, and explore potential mechanisms by which gut microbiome modulation may impact the brain in AD. The research will be...
This $1,102,206 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a research project titled "CRCNS: Repurposing Transformers to Characterize Gut Microbiome & Aging Brain Axis" at the University of Wisconsin - Madison. The project aims to design specialized transformer-based machine learning models to analyze associations between gut microbiome composition and brain health in Alzheimer's disease and other dementias. Key objectives...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $310,000 in funding to Wake Forest University Health Sciences to identify microRNA (miRNA) biomarkers and regulatory targets associated with early cognitive impairment and progression to Alzheimer's disease (AD). The key objectives are to: 1) Identify circulating miRNA biomarkers that can discriminate between individuals at distinct stages of AD progression, including early...
The University of Alabama at Birmingham (UAB) has been awarded a $1,869,019 Project Grant by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The funding will support a 3-year research project to investigate the role of circadian rhythms, gut microbiome, and gut-to-brain signaling in the onset and progression of Alzheimer's disease (AD) using a Drosophila (fruit fly) model. Key objectives include determining whether depletion of gut microbiota...
This Project Grant awarded by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is funding research to investigate the role of oral microbially-induced exosomes in the pathogenesis of Alzheimer's disease (AD) and related dementias (ADRD). The $550,627 award, with a project period from January 1, 2025 to November 30, 2029, is being provided to the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to conduct...